Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure

Circulation

Volumn 96, Issue 8, 1997, Pages 2586-2594

  Ponikowski, Piotr ^a   Chua, Tuan Peng ^a   Piepoli, Massimo ^a   Ondusova, Daniela ^a   Webb Peploe, Katharine ^a   Harrington, Derek ^a   Anker, Stefan D ^a   Volterrani, Maurizio ^c   Colombo, Roberto ^c   Mazzuero, Giorgio ^c   Giordano, Amerigo ^c   Coats, Andrew J S ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c NONE

Author keywords

Autonomic function; Baroreceptors; Chemoreceptors; Heart failure

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD VESSEL COMPLIANCE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DILATATION; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; HYPEROXIA; ISCHEMIC HEART DISEASE; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL;

EID: 0342617574     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2586     Document Type: Article

References (54)

1. Francis GS, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984;101:370-377.
2. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993; 4(suppl A):72A-84A.
3. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
4. Mancia G, Seravalle G, Giannattasio C, Bossi M, Preti L, Cattaneo BM, Grassi G. Reflex cardiovascular control in congestive heart failure. Am J Cardiol. 1992;69:17G-23G.
5. Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM. Arterial compliance may influence baroreflex function in athlets and hypertensives. Am J Physiol. 1995;268:H411-H418.
6. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJS. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation. 1996;93:940-952.
7. Chua TP, Clark AL, Amadi AA, Coats AJS. The relationship between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1996;27:650-657.
8. Mancia G. Influence of carotid baroreceptors on vascular responses to carotid chemoreceptor stimulation in the dog. Circ Res. 1975;36: 270-276.
9. Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87:1953-1957.
10. Pisarri TE, Kendrick JE. Reduced effectiveness of the carotid baroreflex during arterial hypoxia in dogs. Am J Physiol. 1984;247: H623-H630.
11. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
12. Parati G, Saul JP, DiRienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension. 1995;25:1276-1286.
13. Colombo R, Mazzuero G, Soffiantino F, Ardizzola M, Minuco G. A comprehensive PC solution to heart rate variability: analysis in mental stress. Comp Cardiol. 1989;475-478.
14. Sleight P, La Rovere MT, Mortara A, Pinna G, Maestri R, Leuzzi S, Bianchini B, Tavazzi L, Bernardi L. Physiology and pathophysiology of heart rate and blood pressure variability: is power spectral analysis largely and index of baroreflex gain? Clin Sci. 1995;88: 103-109.
15. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic heart failure by heart rate spectral analysis. Am J Cardiol. 1988;61:1292-1299.
16. Stein PK, Bosner M, Kleiger RE, Cogner BM. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J. 1994;127: 1376-1381.
17. Ponikowski P, Chua TP, Amadi AA, Piepoli M, Harrington D, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJS. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. Am J Cardiol. 1996;77:1320-1326.
18. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerruti S, Sleight P, Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension. 1998;12:600-610.
19. Lucini D, Pagani M, Mela GS, Malliani A. Sympathetic restraint of baroreflex control of heart period in normotensive and hypertensive subjects. Clin Sci. 1994;86:547-556.
20. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res. 1969;24:109-121.
21. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation. 1988;78:816-824.
22. Chua TP, Coats AJS. The reproducibility and comparability of tests of the peripheral chemoreflex: comparing the transient hypoxic ventilatory drive test and the single-breath carbon dioxide response test in healthy subjects. Eur J Clin Invest. 1995;25:887-892.
23. Lipkin DP, Perrins J, Poole-Wilson PA. Respiratory gas exchange in the assessment of patients with impaired ventricular function. Br Heart J. 1985;54:321-328.
24. Piepoli M. Cardiovascular and Ventilatory Responses to Exercise in Chronic Heart Failure. London, UK: Imperial College of Science, Technology and Medicine, University of London; 1996. Thesis.
25. Hannhart B, Michalski H, Delorme N, Chapparo G, Polu J. Reliability of six pulse oximeters in chronic obstructive pulmonary disease. Chest. 1991;99:842-846.
26. Edelman NH, Epstein PE, Lahiri S, Cherniack NS. Ventilatory responses to transient hypoxia and hypercapnia in man. Resp Physiol. 1973;17:302-314.
27. Shaw RA, Schonfeld SA, Whitcomb M. Progressive and transient hypoxic ventilatory drive tests in healthy subjects. Am Rev Respir Dis. 1982;126:37-40.
28. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
29. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
30. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vitali S, Giannattasio C, Del Bo A, Sala C, Bolla G, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
31. Fergusson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990;16:1125-1134.
32. Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance in the progression of chronic heart failure. Eur Heart J. 1995;16:1100-1107.
33. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model. J Am Coll Cardiol. 1991;18:464-472.
34. Eaton GM, Cody RJ, Nunziata E, Binkley PF. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced model of congestive heart failure. Circulation. 1995;92:555-561.
35. Middlekauff HR, Hamilton MA, Stevenson LW, Mark AL. Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation. 1994;90:1794-1798.
36. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, Ceconi C, Cerutti S, Tavazzi L. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J. 1994;71:422-430.
37. Bernardi L, Salvucci F, Suardi R, Solda' PL, Calciati A, Perlini S, Falcone C, Ricciardi L. Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc Res. 1990;24: 969-981.
38. Miura M, Reis DJ. The role of the solitary and paramedian reticular nuclei in mediating cardiovascular reflex responses from carotid baro- and chemoreceptors. J Physiol (Lond). 1972;223: 525-548.
39. Trzebski A. Arterial chemoreceptor reflex and hypertension. Hypertension. 1992;19:562-565.
40. Weil JV, Byrne-Qiunn E, Sodal IE, Kline JS, McCullough RE, Filley GF. Augmentation of chemosensitivity during mild exercise in normal man. J Appl Physiol. 1972;33:813-819.
41. Harris P. Congestive heart failure: central role of arterial blood pressure. Br Heart J. 1987;58:190-203.
42. van de Borne P, Oren R, Anderson EA, Mark AL, Somers VK. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation. 1996; 94:1325-1328.
43. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996;27: 353-357.
44. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med. 1989;111:777-782.
45. Naughton M, Benard D, Tam A, Rutherford R, Bradley TD. Role of hyperventilation in the pathogenesis of cental sleep apneas in patients with congestive heart failure. Am Rev Respir Dis. 1993;148: 330-338.
46. Davies SW, John LM, Wedzicha JA, Lipkin DP. Overnight studies in severe chronic heart failure: arrhythmias and oxygen desaturation. Br Heart J. 1991;65:77-83.
47. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473-479.
48. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996;153:272-276.
49. Adamopoulos S, Piepoli M, McCance A, Bernardi L, Radaelli A, Ormerod O, Forfar C, Sleight P. Comparison of different methods for assessing sympathovagal balance in chronic heart failure secondary to coronary artery disease. Am J Cardiol. 1992; 70:1576-1582.
50. Cormack RS, Cunningham DJC, Gee JBL. The effect of carbon dioxide on the respiratory response to want of oxygen. Q J Exp Physiol. 1957;42:323-334.
51. Rebuck AS, Campbell EJM. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis. 1974;109: 345-350.
52. Kronenberg R, Hamilton FN, Gabel R, Hickey R, Read DJC. Comparison of three methods for quantitating respiratory response to hypoxia in man. Resp Physiol. 1972;16:109.
53. Tuininga YS, van Veldhuisen DJ, Brouver J, Haaksma J, Crijns HJGM, Man in't Veld AJ, Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J. 1994;72:509-513.
54. Fergusson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation. 1989;80:65-77.